|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,198.85 INR | -0.10% |
|
+1.13% | -11.01% |
| Market Cap | 37TCr 394.4Cr 339.89Cr 312.99Cr 293.87Cr 551.74Cr 557.56Cr 3.7TCr 1.44TCr 18TCr 1.48TCr 1.45TCr 63TCr | P/E Ratio 2027 * |
32.7x | P/E Ratio 2028 * | 29x |
|---|---|---|---|---|---|
| Enterprise Value | 37TCr 394.4Cr 339.89Cr 312.99Cr 293.87Cr 551.74Cr 557.56Cr 3.7TCr 1.44TCr 18TCr 1.48TCr 1.45TCr 63TCr | EV / Sales 2027 * |
8.89x | EV / Sales 2028 * | 8.03x |
| Free-Float |
24.36% | Yield 2027 * |
1.34% | Yield 2028 * | 1.34% |
Last Transcript: GlaxoSmithKline Pharmaceuticals Limited
| 1 day | -0.10% | ||
| 1 week | +1.13% | ||
| Current month | -0.45% | ||
| 1 month | -7.97% | ||
| 3 months | -9.65% | ||
| 6 months | -14.83% | ||
| Current year | -11.01% |
| 1 week | 2,088 |  | 2,210 |
| 1 month | 2,088 | | 2,435.05 |
| Current year | 2,088 | | 2,715.15 |
| 1 year | 2,088 | | 3,500 |
| 3 years | 1,376.5 | | 3,515.95 |
| 5 years | 1,228 | | 3,515.95 |
| 10 years | 1,020 | | 3,515.95 |
| Manager | Title | Age | Since |
|---|---|---|---|
Bhushan Akshikar
CEO | Chief Executive Officer | 56 | 01/12/2022 |
Ronojit Biswas
DFI | Director of Finance/CFO | - | 01/04/2026 |
Shalini Menon
CTO | Chief Tech/Sci/R&D Officer | - | 08/07/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Subesh Williams
BRD | Director/Board Member | 64 | 07/04/2017 |
Renu Sud Karnad
CHM | Chairman | 73 | 01/04/2019 |
| Director/Board Member | 59 | 18/05/2020 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.10% | +1.13% | -32.39% | +55.44% | 394.4Cr | |
| -0.61% | -1.94% | +39.00% | +150.72% | 1,00100Cr | |
| -0.20% | -0.77% | +51.51% | +43.20% | 57TCr | |
| +0.40% | -1.31% | +16.56% | +60.47% | 39TCr | |
| +0.46% | +2.29% | +24.04% | +16.53% | 33TCr | |
| +0.13% | +0.57% | +25.27% | +31.78% | 28TCr | |
| +0.53% | -0.89% | +25.15% | +14.58% | 28TCr | |
| +2.34% | +1.01% | -41.40% | -47.18% | 19TCr | |
| -0.77% | +0.95% | +17.69% | +51.46% | 19TCr | |
| +2.36% | +1.38% | +14.80% | +61.34% | 16TCr | |
| Average | +0.72% | +0.35% | +14.02% | +43.83% | 33.81TCr | |
| Weighted average by Cap. | +0.64% | -0.41% | +27.81% | +67.37% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 4.19TCr 44Cr 38Cr 35Cr 33Cr 62Cr 63Cr 415.97Cr 162.05Cr 2.05TCr 166.47Cr 162.94Cr 7.12TCr | 4.65TCr 49Cr 42Cr 39Cr 37Cr 69Cr 69Cr 460.74Cr 179.49Cr 2.27TCr 184.39Cr 180.48Cr 7.88TCr |
| Net income | 1.14TCr 12Cr 10Cr 9.57Cr 8.99Cr 17Cr 17Cr 113.09Cr 44Cr 558.34Cr 45Cr 44Cr 1.93TCr | 1.29TCr 14Cr 12Cr 11Cr 10Cr 19Cr 19Cr 127.68Cr 50Cr 630.38Cr 51Cr 50Cr 2.18TCr |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/26/17 | 2,198.85 ₹ | -0.10% | 8,187 |
| 16/26/16 | 2,201.15 ₹ | +3.60% | 29,606 |
| 15/26/15 | 2,124.65 ₹ | +0.19% | 8,207 |
| 12/26/12 | 2,120.70 ₹ | +0.86% | 3,53,278 |
| 11/26/11 | 2,102.70 ₹ | -3.29% | 4,881 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GLAXO Stock
Select your edition
All financial news and data tailored to specific country editions
